PROVIDER PROFILE · NPI 1356858211

Ankica Katic

MEDICARE UTILIZATION · PART B · 2024

No data available for this provider in 2024.

PRESCRIBING · PART D · 2024

Total Rx claims

Beneficiaries

—

Total drug cost

$304K

Distinct drugs

Brand share

84.7%

Top prescribed drugs

QUALITY · MIPS · 2024

Final MIPS score

81.2

Quality

63.1

Cost

74.2

Improvement activities

40.0

Promoting interop.

100.0

Payment adjustment

0.26%

Group

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

CROSS-REFERENCE

Related data on other Healthparse brands